CClinicalTrials.gg
Status unknownNCT03382002Updated Feb 1, 2019

Association Between Oxidative Parameters in Fertilization Medium of Cumulus Oocyte Complex and Outcome in IVF

An observational study in Oxidative Stress, sponsored by Carmel Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2019-02-01.

Sponsored by Carmel Medical Center · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
322
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Medium of cumulus-oocyte complex will be assessed for oxidative status.

02

Conditions studied

  • Oxidative Stress
03

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing in vitro fertilization

Inclusion criteria

•Patients undergoing in vitro fertilization treatment

Exclusion criteria

Exclusion Criteria:

•Patients undergoing intracytoplasmic sperm injection

04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
322 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testTCL

    evaluation of oxidative status

05

What researchers measure

Primary outcomes

  1. Association of parameters of oxidative state with cycle outcome (pregnancy: yes/no)

    The oxidative status in the incubation medium of the cumulus-oocyte complex will be assessed looking for an association between oxidative parameters and cycle outcome (pregnancy: yes/no))

    Time frame: two years

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03382002
Lead sponsor
Carmel Medical Center
Responsible party
Zofnat Wiener (Principal investigator, Carmel Medical Center) — Principal investigator
First posted
Dec 22, 2017
Start date
Nov 28, 2017
Primary completion
Nov 28, 2019 (estimated)
Completion
Apr 28, 2020 (estimated)
Last update
Feb 1, 2019

Study contacts

Zofnat Wiener, MD
Contact
wiener_zofnat@clalit.org.il
97248250335

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion